From: The significance of macrophage phenotype in cancer and biomaterials
Biomaterial property | Macrophage response |
---|---|
Large fibers and pores (PDO) | M2 response, wound healing, angiogenesis [123] |
Fiber size | |
~0.6 μm (PLLA) | Minimal M1 activation, low FBGC population [121] |
~1.6 μm (PLLA) | High FBGC population [121] |
Hydrogels with pores (30–40 μm) (pHEMA-co-MAA) | M2 dominated, maximum vascularization, minimum fibrotic response [132] |
Microgel coating (pNIPAm-co-PEGDA) | Reduction of M1 activation and cytokine secretion [124] |
Zwitterionic hydrogels | Anti-inflammatory, pro-healing M2 macrophages, angiogenesis, no fibrous capsule [125] |
Subintestinal submucosa | Â |
Crosslinked with carbodiimide | M1 bias, chronic inflammation, prolonged healing [24] |
Non-crosslinked | M2 bias, constructive remodeling [24] |
Acetylated chitosan | Â |
5% acetylated | |
15% acetylated | |
Glutaraldehyde crosslinked collagen | M1/M2 balance, improved vascularization [143] |
Biologically-derived scaffolds | Â |
Porcine submucosa, urinary bladder | M2, timely constructive tissue remodeling [23] |
Human, porcine dermis | M1, prolonged healing [23] |